Company page
Abl Bio, Inc.
Abl Bio, Inc. is a public company listed under the ticker 298380 on the Korean market. The company has a market capitalization of approximately 3.66 trillion KRW. Abl Bio focuses on biopharmaceutical development, aiming to advance innovative therapies in the healthcare sector.
- Ticker
- 298380:KRX
- Asset type
- Stock
- Market cap
- $3.66B
- Sector
- Health Technology
- Industry
- Pharmaceuticals: Major
- Exchange
- KRX
- Currency
- KRW